BRIEF-Immunogen sees FY 2017 revenue $70 mln to $75 mln By: Reuters: Company News February 17, 2017 at 06:51 AM EST * Immunogen reports recent progress and operating results for six-month period and quarter ended December 31, 2016 Read More >> Related Stocks: Immunogen Inc